Integrin-Mediated Delivery of Drugs and Nucleic Acids for Anti-Angiogenic Cancer Therapy: Current Landscape and Remaining Challenges

Bioengineering - Switzerland
doi 10.3390/bioengineering5040076
Full Text
Abstract

Available in full text

Categories
Bioengineering
Date
Authors
Publisher

MDPI AG

Related search

Anti-Angiogenic Therapy for Cancer: Current Progress, Unresolved Questions and Future Directions

Angiogenesis
Cancer ResearchClinical BiochemistryPhysiology
2014English

Delivery of Nucleic Acids and Nanomaterials by Cell-Penetrating Peptides: Opportunities and Challenges

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?

Expert Review of Anti-Infective Therapy
VirologyInfectious DiseasesMicrobiology
2020English

The Evolving Landscape of Treatment for Advanced Gastric Cancer and the Role of Anti-Angiogenic Therapy: Implications From Results of the INTEGRATE Study

Translational Gastroenterology and Hepatology
2017English

Nanoparticles Escaping RES and Endosome: Challenges for siRNA Delivery for Cancer Therapy

Journal of Nanomaterials
Materials ScienceNanotechnologyNanoscience
2011English

Nanocarrier Mediated Delivery of siRNA/miRNA in Combination With Chemotherapeutic Agents for Cancer Therapy: Current Progress and Advances

Journal of Controlled Release
Pharmaceutical Science
2014English

Phospholipid Conjugate for Intracellular Delivery of Peptide Nucleic Acids

Bioconjugate Chemistry
Organic ChemistryBiotechnologyPharmacologyPharmaceutical ScienceBioengineeringBiomedical Engineering
2009English

Anti‐angiogenic Therapies for Gastric Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2019English

Surface- And Hydrogel-Mediated Delivery of Nucleic Acid Nanoparticles

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy